🇺🇸 FDA
Patent

US 7759348

Pyridazine derivatives and their use as therapeutic agents

granted A61KA61K31/00A61K31/501

Quick answer

US patent 7759348 (Pyridazine derivatives and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/00, A61K31/501, A61K31/551, A61P